| Item Type | Name |
|
Concept
|
Immunosuppressive Agents
|
|
Academic Article
|
FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
|
|
Academic Article
|
Outcome of monoclonal antibody induction and anti-rejection therapy in pancreas transplantation.
|
|
Academic Article
|
Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients.
|
|
Academic Article
|
Tacrolimus therapy for refractory renal allograft rejection: experience with steroid withdrawal.
|
|
Academic Article
|
OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
|
|
Academic Article
|
Posttransplant lymphoproliferative disease in pediatric liver transplantation. Interplay between primary Epstein-Barr virus infection and immunosuppression.
|
|
Academic Article
|
Cyclosporine versus cyclosporine microemulsion in pediatric liver transplant recipients.
|
|
Academic Article
|
Tacrolimus/mycophenolate provides superior immunosuppression relative to neoral/mycophenolate in synchronous pancreas-kidney transplantation.
|
|
Academic Article
|
Tacrolimus therapy for refractory acute renal allograft rejection: a prospective multicenter trial. Tacrolimus Kidney Transplantation Rescue Study Group.
|
|
Academic Article
|
Role of protocol biopsies in the treatment of refractory renal allograft rejection with FK 506.
|
|
Academic Article
|
Liver transplantation in the first three months of life.
|
|
Academic Article
|
Effects of tacrolimus, mycophenolate mofetil, and cyclosporine microemulsion on rejection incidence in synchronous pancreas-kidney transplantation.
|
|
Academic Article
|
A multicenter trial of FK506 (tacrolimus) therapy in refractory acute renal allograft rejection. A report of the Tacrolimus Kidney Transplantation Rescue Study Group.
|
|
Academic Article
|
Transplantation.
|
|
Academic Article
|
Association between liver transplantation for Langerhans cell histiocytosis, rejection, and development of posttransplant lymphoproliferative disease in children.
|
|
Academic Article
|
Clinical course and management of inflammatory bowel disease after liver transplantation.
|
|
Academic Article
|
Tacrolimus treatment of steroid-resistant rejection provides economic advantages compared with OKT3 therapy.
|
|
Academic Article
|
Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
|
|
Academic Article
|
Humanized, nonmitogenic OKT3 antibody, huOKT3 gamma(Ala-Ala): initial clinical experience.
|
|
Academic Article
|
Modified surgical model of paratopic small bowel transplantation in mice.
|
|
Academic Article
|
Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
|
|
Academic Article
|
Reversal of accelerated renal allograft rejection with FK 506.
|
|
Academic Article
|
Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
|
|
Academic Article
|
Successful use of tacrolimus for initial rejection episodes after liver transplantation.
|
|
Academic Article
|
The clinical and pathologic implications of plasmacytic infiltrates in percutaneous renal allograft biopsies.
|
|
Academic Article
|
Induction, maintenance, and reversal of streptozotocin-induced insulin-dependent diabetes mellitus in the juvenile cynomolgus monkey (Macaca fascilularis).
|
|
Academic Article
|
Evaluation of pre- and posttransplant donor-specific transfusion/cyclosporine A in non-HLA identical living donor kidney transplant recipients. Cooperative Clinical Trials in Transplantation Research Group.
|
|
Academic Article
|
The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies.
|
|
Academic Article
|
Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection.
|
|
Academic Article
|
Transplantation and the CD28/CTLA4/B7 pathway.
|
|
Academic Article
|
Role of STAT6 signaling in the induction and long-term maintenance of tolerance mediated by CTLA4-Ig.
|
|
Academic Article
|
Reduced acute rejection and superior 1-year renal allograft survival with basiliximab in patients with diabetes mellitus. The Global Simulect Study Group.
|
|
Academic Article
|
Calcium and calcitriol prophylaxis attenuates posttransplant bone loss.
|
|
Academic Article
|
Selective OKT3 induction therapy in adult cadaveric-donor renal transplant recipients.
|
|
Academic Article
|
Low-dose anti-CD3 therapy provides long-term graft survival in a Lewis rat to C57BL/6 xeno-islet transplantation model.
|
|
Academic Article
|
Potent immunosuppression overcomes immunologic high-risk factors in recipients of cadaveric renal allografts.
|
|
Academic Article
|
T cell immunofluorescence flow cytometry cross-match results in cadaver donor renal transplantation.
|
|
Academic Article
|
Long-term survival of xenogeneic pancreatic islet grafts induced by CTLA4lg.
|
|
Academic Article
|
A non-activating "humanized" anti-CD3 monoclonal antibody retains immunosuppressive properties in vivo.
|
|
Academic Article
|
Tacrolimus for primary treatment of steroid-resistant hepatic allograft rejection.
|
|
Academic Article
|
OKT3 prophylaxis in renal grafts with prolonged cold ischemia times: association with improvement in long-term survival.
|
|
Academic Article
|
Tacrolimus therapy for refractory acute renal allograft rejection: definition of the histologic response by protocol biopsies.
|
|
Academic Article
|
Corticosteroid cessation 1 week following renal transplantation using tacrolimus/mycophenolate mofetil based immunosuppression.
|
|
Academic Article
|
Orthotopic auxiliary liver transplantation for Crigler-Najjar syndrome type 1.
|
|
Academic Article
|
Kidney transplantation: graft monitoring and immunosuppression.
|